Skip to main content

ADVERTISEMENT

Yin Yang, MS

Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States
Research Reports
02/18/2020
Andrew J Klink, PhD, MPH
Chadi Nabhan, MD, MBA, FACP
Choo Hyung Lee, MS
JaLyna Laney, RN, OCN
Yin Yang, MS
Anna G Purdum, PharmD, MS
Bruce A Feinberg, DO
Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...
Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...
...
02/18/2020
Journal of Clinical Pathways